Prevalence of glutamic acid decarboxylase antibodies amongst young Malaysian diabetics

Diabetes Research and Clinical Practice

Volumn 43, Issue 1, 1999, Pages 59-66

  Wan Nazaimoon, W M ^a   Faridah, I ^b   Singaraveloo, M ^c   Ismail, I S ^d   Wan Mohamad, W B ^e   Letchuman, R ^f   Rasat, R ^b   Pendek, R ^d   Hew, F L ^d   Sheriff, I H ^b   Khalid, B A K ^b  

^a INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^b DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^c HOSPITAL SULTANAH AMINAH   (Malaysia)

^d UNIVERSITY OF MALAYA   (Malaysia)

^e SCHOOL OF PHYSICS   (Malaysia)

^f General Hospital Kota Bharu   (Malaysia)

Author keywords

Chinese; Glutamic acid decarboxylase antibodies; Indian; Malay

Indexed keywords

ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHINESE; CONTROLLED STUDY; FEMALE; HUMAN; INDIAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALAYSIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE DIFFERENCE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ANTIBODIES; CHILD; CHILD, PRESCHOOL; CHINA; DIABETES MELLITUS; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INDIA; INFANT; MALAYSIA; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

EID: 0032974525     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(98)00108-9     Document Type: Article

References (26)

1. Atkinson M.A., Maclaren N.K., Scharp D.W., Lacy P.E., Riley W.J. 64 000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet. 335:1990;1357-1360.
2. Tuomilehto J., Zimmet P., Mackay I.R., Koskela P., Vidgren G., Toivanen L., Tuomilehto-Wolf E., Kohtamaki K., Stengard J., Rowley M.J. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet. 343:1994;1383-1385.
3. Bingley P.J., Bonifacio E., Williams A.J., Genovese S., Bottazzo G.F., Gale E.A. Prediction cf IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes. 46:1997;1701-1710.
4. Bonifacio E., Lampasona V., Genovese S., Ferrari M., Bosi E. Identification of protein tyrosine phosphatase-like IA2 (islet cell antgen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell autoantibodies. J. Immunol. 155:1995;5419-5426.
5. Niskanen L.K., Tiinamaija T., Karjelainen J., Groop L.C., Uusituoa M.l.J. GAD antibodies in NIDDM: ten-year follow-up from diagnosis. Diab. Care. 18:1995;1557-1565.
6. . Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes. 42:1993;359-362.
7. R.S. Schmidli, P.G. Colman, E. Bonifacio, and participating laboratories, Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies, Diabetes 44 (1995) 636-640.
8. Tuomi T., Zimmet P., Rowley M.J., Min H.K., Vichayanrat A., Lee H.K., Rhee B.D., Vannasaeng S., Humphrey A.R., Mackay I.R. Differing frequency of autoantibodies to glutamic acid decarboxylase among Koreans, Thais, and Australians with diabetes mellitus. Clin. Immunol. Immunopathol. 74:1995;202-206.
9. Lee H.C., Cha B.S., Nam M.S. Relationships among 64K autoantibodies pancreatic beta-cell function HLA-DR antigens and HLA DQ genes in patients with insulin-dependent diabetes mellitus in Korea. Korean J. Intern. Med. 10:1995;1-9.
10. Chan J.C., Yeung V.T., Chow C.C., Mackay I.R., Rowley M.I., Zimmet P.Z., Cockram C.S. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus. Diab. Res. Clin. Prac. 32:1996;27-34.
11. West K.W., Kalbfleish J.M. Glucose tolerance, nutrition and diabetes in Uruguay, Venezuela, Malaysia, and East Pakistan. Diabetes. 15:1966;8-9.
12. Pillay R.P., Lim T.0 Incidence of diabetes mellitus in Malaya. Med. J. Malaya. 16:1960;242-244.
13. Ali O., Tan T.T., Sakinah O., Khalid B.A.K., Wu L.L., Ng M.L. Prevalence of NIDDM and impaired glucose tolerance in Aborigines and Malays in Malaysia and their relationship to sociodemographic, health, and nutritional factors. Diab. Care. 16:1993;68-75.
14. Khebir B.V., Osman A., Khalid B.A.K. Diabetes mellitus among rural Malays in Kuala Selangor: risk factors and trend. Med. J. Malaysia. 51:1996;41-47.
15. Khalid B.A.K., Ng M.L., Nurshaireen B.A., Peggiwati K., Nasaruddin B.A., Abu Hassan B.S. Childhood diabetes in Malaysia. Const. Med. 55:1992;S34-37.
16. Gjessing H.J., Matzen L.E., Froland A., Faber O.K. Correlations between fasting plasma C-peptide glucagon-stimulated plasma C-peptide and urinary C-peptide in insulin-treated diabetics. Diab. Care. 10:1987;487-490.
17. Hagopian W.A., Sanjeevi C.B., Kockum I., Landin-Olsson M., Karlsen A.E., Sundkvist G., Dahlquist G., Palmer J., Lernmark A. Glutamate decarboxylase, insulin- and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J. Clin. Invest. 95:1995;1505-1511.
18. Tsuruoka A., Matsuba I., Toyota T., Isshiki G., Nagataki S., Ikeda Y. Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes Res. Clin. Pract. 28:1995;191-199.
19. Rattarasarn C., Aguilar-Diosdado M., Soonthornpun S., Patarakijvanich N., Jaruratanasirikul S. GAD antibodies in IDDM in Thailand. Diab. Care. 19:1996;674-675.
20. J. Tuomilehto, M. Karvonen, Z. Padaiga, E. Tuomilehto-Wolf, K. Kohtamaki for the DIABALT Study Group, Epidemiology of insulin-dependent diabetes mellitus around the Baltic Sea, Horm. Metab. Res. 28 (1996) 340-343.
21. Thai A.C., Ng W.Y., Loke K.Y., Lee W.R., Lui K.F., Cheah J.S. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM. Diabetologia. 40:1997;1425-1430.
22. Mohan V., Deepa R., Bhatta E., Singh A.K., Hitman G.A., Zimmet P.Z., MacKay I.R. Antibodies to pancreatic islet cell antigens in diabetes seen in Southern India with particular reference to fibrocalculous pancreatic diabetes. Diab. Med. 15:1998;156-159.
23. Dorman J.S., LaPorte R.E., Stone R.A., Trucco M. Worldwide differences in the incidence of type 1 diabetes are associated with amino acid variation at position 57 of the HLA-DQ B chain. Proc. Natl. Acad. Sci. USA. 87:1990;7370-7374.
24. Kockum I., Lernmark A., Dahlquist G., Falorni A., Hagopian W.A., Landin-Olsson M., Li L.C., Luthman H., Palmer J.P., Sanjeevi C.B., Sundkvist G., Ostman J. The Swedish Childhood Diabetes Study Group and The Diabetes Incidence in Sweden Study (DISS) Group. Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus. Horm. Metab. Res. 28:1996;344-347.
25. Ostman J., Lernmark A., Landin-Olsson M., Sundkvist G., Palmer J., Arnqvist H., Blohme G., Littorin B., Nystrom L., Schersten B., Wibell L. Autoimmune (Type 1) diabetes in young adults in Sweden. Horm. Metab. Res. 28:1996;348-350.
26. Zimmet P.Z., Tuomi T., Mackay I.R., Rowley M.J., Knowles W., Cohen M. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetic Med. 11:1994;299-303.